Common side effects in Phase 2 were gastrointestinal (nausea, vomiting, diarrhoea), dose-dependent, and generally transient
Davis EM, and Sandoval DA
Tesamorelin provides researchers with a model for understanding hormone-driven changes in metabolism and recovery at a cellular level
UCLA physicians have pointed out that the common risk of significant weight loss on GLP-1 drugs is being accompanied by sarcopenia, which can cause long-term negative health implications, such as increased fracture risk, decreased mobility, lowered metabolism, and reduced quality of life
Alternately, some individuals may be able to successfully transition to an older generation medication
Its most popular service is its Weight Management Program with GLP-1 medications